The latest pulmonology news from News Medical
Can't see this email? View it online
   
  Pulmonology  
  The latest pulmonology news from News Medical  
 What does the future look like for TB care?What does the future look like for TB care?
 
In this interview, we speak to Charles Wells from Gates MRI about their current research into tuberculosis (TB) as well as the recent updated guidelines for TB care.
 
 
 How does the flu vaccine affect the risk of contracting COVID-19?How does the flu vaccine affect the risk of contracting COVID-19?
 
A new study describes the association between the risk of contracting COVID-19 and the seasonal flu vaccine.
 
   BCG vaccine produces a "trained immunity response" which lasts more than a yearBCG vaccine produces a "trained immunity response" which lasts more than a year
 
The immune boosting benefits of a tuberculosis vaccine can be seen in infants more than one year after vaccination, according to a new study.
 
   A combined influenza and COVID-19 mRNA vaccineA combined influenza and COVID-19 mRNA vaccine
 
A combined mRNA vaccine is capable of inducing broad and durable protection against co-infection with SARS-CoV-2 and IAV,
 
   Fatigue and headache among the most common symptoms following COVID-19 infectionsFatigue and headache among the most common symptoms following COVID-19 infections
 
Fatigue and headache were the most common symptoms reported by individuals an average of more than four months out from having COVID-19, investigators report.
 
   Gut microbiota-derived metabolites offer protection against SARS-CoV-2Gut microbiota-derived metabolites offer protection against SARS-CoV-2
 
A new study investigated how the gut microbiome confers immunity to mammalian hosts against SARS-CoV-2 intranasal infection by generating short-chain fatty acids.
 
 Pediatric adjuvant formulation offers protection against RSV in newborns
 
Pediatric adjuvant formulation offers protection against RSV in newbornsRespiratory syncytial virus (RSV) is the leading global cause of death in children under age 5 and lacks an effective vaccine. In a study from the Precision Vaccines Program at Boston Children's Hospital, a new vaccine formulation protected newborn mice against infection and evoked strong responses in immune cells from human newborns in the laboratory. Results were reported August 2 in Nature Communications.
 
 
 New recommendations on how to determine eligibility criteria for lung cancer clinical trials
 
New recommendations on how to determine eligibility criteria for lung cancer clinical trialsA clinical trial is only as powerful as its participants. For years, researchers have struggled to fill clinical trials and enroll sufficiently diverse groups of patients for results to reflect the broader population, in part because of stringent guidelines on who can participate.
 
 
 Research highlights the need to increase early detection of lung cancer among younger patients
 
Research highlights the need to increase early detection of lung cancer among younger patientsYounger patients with lung cancer are significantly more likely than older patients to be diagnosed with later stages of disease, illustrating the need to develop strategies to increase the early detection of lung cancer among younger patients who are currently ineligible for lung cancer screening.
 
 
 Genetic signatures may help predict immunotherapy response in patients with bladder cancer
 
Genetic signatures may help predict immunotherapy response in patients with bladder cancerInvestigators from Cedars-Sinai Cancer have identified genetic signatures that could predict whether tumors in patients with bladder and other cancers will respond to immunotherapy.
 
 
 'RNA fishing' technique identifies several proteins involved in the progression of melanoma
 
'RNA fishing' technique identifies several proteins involved in the progression of melanomaResearchers at the Centre for Genomic Regulation have identified several proteins involved in the progression of melanoma, the deadliest form of skin cancer.
 
 
 Five-year, $2.7 million grant could help determine the best treatment for lung cancer patients
 
Five-year, $2.7 million grant could help determine the best treatment for lung cancer patientsThe goal: Improve survival rates for lung cancer patients. The question researchers want to answer: Are there new ways to determine the best treatment for these patients?
 
 
 Johns Hopkins Medicine-led consortium awarded up to $200 million to address the global burden of tuberculosis
 
Johns Hopkins Medicine-led consortium awarded up to $200 million to address the global burden of tuberculosisTo address the global burden of tuberculosis (TB), one of humankind's oldest scourges, an international collaboration led by Johns Hopkins Medicine has today been awarded up to $200 million in research funding over five years by the U.S. Agency for International Development (USAID) Supporting, Mobilizing and Accelerating Research for Tuberculosis Elimination (SMART4TB) project.
 
 
 Sub lobar surgery found to be non-inferior to lobectomy for patients with small-sized peripheral NSCLC
 
Sub lobar surgery found to be non-inferior to lobectomy for patients with small-sized peripheral NSCLCA large international study of patients with non-small cell lung cancer tumors that are two centimeters or less found that sub lobar surgery was non-inferior to lobectomy, according to results presented today at the IASLC World Conference on Lung Cancer 2022 in Vienna.
 
 
 Finding the lowest effective dose of asthma preventer medicine
 
Finding the lowest effective dose of asthma preventer medicineSeven out of ten Australians with asthma aged over 12 years may be prescribed too much preventer medicine. In Australian Prescriber Prof Helen Reddel and coauthors from the Woolcock Institute of Medical Research write about finding the lowest effective dose to control asthma.
 
 
 First Phase II study of immunotherapy combined with curative radiotherapy for unresectable locally advanced NSCLC
 
First Phase II study of immunotherapy combined with curative radiotherapy for unresectable locally advanced NSCLCResearchers from Japan today reported that the first phase II study to evaluate the efficacy and safety of durvalumab and concurrent curative radiation therapy for PD-L1-positive unresectable locally advanced non-small cell lung cancer without chemotherapy met its primary endpoint with tolerable adverse reactions.
 
 
 Combination therapy regimen for cystic fibrosis is also beneficial to primary school-aged children
 
Combination therapy regimen for cystic fibrosis is also beneficial to primary school-aged childrenCystic fibrosis remains an incurable genetic disorder which impairs lung function and significantly reduces life expectancy.
 
 
 Smaller lung airways in women can lead to a higher risk for COPD
 
Smaller lung airways in women can lead to a higher risk for COPDStructural differences in lung airways between men and woman may be the cause of differences in chronic obstructive pulmonary disease (COPD) prevalence and outcomes between the sexes.